INTEGRA LIFESCIENCES HOLDINGS CORPORATION
CONSOLIDATED FINANCIAL RESULTS
(In thousands, except per share data)
(UNAUDITED)
Statement of Operations Data:
Three Month Period Six Month Period
Ended June 30 Ended June 30
2001 2000 2001 2000
------- ------ ------- -------
Product sales $21,385 $15,827 $41,669 $29,159
Other revenue 1,535 1,259 2,935 2,458
------- ------ ------- -------
Total revenue 22,920 17,086 44,604 31,617
Cost of product sales 8,310 7,212 16,904 13,899
Research and development 1,837 2,004 3,910 3,894
Selling and marketing 5,269 3,904 10,020 6,853
General and administrative 3,319 3,884 6,523 7,631
Amortization 729 670 1,409 1,150
------- ------ ------- -------
Total costs and expenses 19,464 17,674 38,766 33,427
Operating income (loss) 3,456 (588) 5,838 (1,810)
Gain on disposition of product line -- 1,031 -- 1,146
Other expense, net (265) (170) (405) (36)
------- ------ ------- -------
Income (loss) before income taxes 3,191 273 5,433 (700)
Provision for income taxes 429 161 675 223
------- ------ ------- -------
Income (loss) before accounting change 2,762 112 4,758 (923)
Cumulative effect of accounting change -- -- -- (470)
------- ------ ------- -------
Net income (loss) $ 2,762 $ 112 $ 4,758 $(1,393)
Earnings (loss) per share
Basic $ 0.12 $ (0.02) $ 0.20 $ (0.36)
Diluted $ 0.10 $ (0.02) $ 0.18 $ (0.36)
Weighted average Common shares outstanding:
Basic 20,245 17,341 19,931 17,282
Diluted 25,049 17,341 22,211 17,282
Balance Sheet Data:
30-JUN 31-DEC
2001 2000
------ ------
Cash, cash equivalents & investments $11,655 $15,138
Working capital 28,299 25,177
Total assets 94,193 86,514
Total debt 9,703 13,630
Total stockholders' equity 62,522 53,781